For the readers interested in the stock health of DermTech Inc. (DMTK). It is currently valued at $2.39. When the trading was stopped its value was $2.32.Recently in News on November 15, 2022, DermTech and Sonora Quest Laboratories Expand Access to Innovative Melanoma Detection Test. Now available to Arizona patients! Non-invasive Smart Stickers™ that lift skin cells to be tested for select genomic markers associated with melanoma. You can read further details here
DermTech Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $17.68 on 01/03/22, with the lowest value was $1.66 for the same time period, recorded on 11/04/22.
DermTech Inc. (DMTK) full year performance was -88.31%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, DermTech Inc. shares are logging -88.60% during the 52-week period from high price, and 43.98% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.66 and $20.96.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 369350 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the DermTech Inc. (DMTK) recorded performance in the market was -84.87%, having the revenues showcasing -61.20% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 74.69M, as it employees total of 255 workers.
Specialists analysis on DermTech Inc. (DMTK)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.96, with a change in the price was noted -3.57. In a similar fashion, DermTech Inc. posted a movement of -59.90% for the period of last 100 days, recording 601,880 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for DMTK is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Trends and Technical analysis: DermTech Inc. (DMTK)
Raw Stochastic average of DermTech Inc. in the period of last 50 days is set at 17.85%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 41.48%. In the last 20 days, the company’s Stochastic %K was 35.63% and its Stochastic %D was recorded 34.55%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -84.87%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -62.77%, alongside a downfall of -88.31% for the period of the last 12 months. The shares increased approximately by -4.40% in the 7-day charts and went up by -25.55% in the period of the last 30 days. Common stock shares were lifted by -61.20% during last recorded quarter.